Antisense strategies to inhibit restenosis

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Biotechnology

Background:

• Restenosis following percutaneous transluminal coronary angioplasty (PTCA) and stenting is a significant clinical challenge.
• Vascular smooth muscle cell (SMC) proliferation and migration are critical in restenosis pathogenesis.
• Phosphorothioate (PS) oligodeoxynucleotides have emerged as potential therapeutic agents.

Purpose of the Study:

• To investigate the efficacy of PS oligodeoxynucleotides in inhibiting SMC proliferation and migration.
• To explore the mechanisms underlying the inhibitory effects of PS oligodeoxynucleotides.
• To evaluate novel strategies for restenosis inhibition.

Main Methods:

• PS oligodeoxynucleotides targeting genes like c-myb, c-myc, cdc2 kinase, cdk2 kinase, and PCNA were used.
• In vitro studies assessed SMC proliferation, migration, and adhesion.
• In vivo studies utilized rat carotid and porcine coronary artery models of balloon injury.
• Experiments included cytidine homopolymers (S-dC28) and guanosine-rich oligodeoxynucleotides (ZK10).
• Novel strategies like E2F transcription decoys and antisense oligonucleotides against bcl-xL were explored.

Main Results:

• PS oligodeoxynucleotides targeting specific genes inhibited in vitro SMC proliferation and migration.
• Adventitial or intraluminal delivery of these PS oligodeoxynucleotides inhibited in vivo neointimal formation.
• Non-G-quartet, non-sequence-specific PS oligodeoxynucleotides (S-dC28) inhibited SMC functions by binding to PDGF and bFGF.
• ZK10 showed potent in vitro inhibition, with comparable in vivo effects to S-dC28.
• PS oligodeoxynucleotides exhibited non-sequence-specific immunomodulatory effects.
• E2F decoys and bcl-xL antisense oligonucleotides reduced neointimal lesion formation and promoted SMC apoptosis.

Conclusions:

• PS oligodeoxynucleotides effectively inhibit SMC proliferation, migration, and neointimal formation.
• Both sequence-dependent and non-sequence-specific mechanisms contribute to their inhibitory effects.
• Novel strategies targeting cell cycle regulation and apoptosis offer promising avenues for restenosis treatment.
• Further research into PS oligodeoxynucleotide properties and delivery methods is warranted.